Eric Aragón
Impact in
-
- TGF-β signaling in diseases
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Chemical Synthesis and Analysis
- Wnt/β-catenin signaling in development and cancer
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
Papers in
-
- TGF-β signaling in diseases 6
- Cancer-related gene regulation 5
- Ubiquitin and proteasome pathways 3
- Glycosylation and Glycoproteins Research 3
- Chemical Synthesis and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- María J. Macias (19 shared papers)Joan Massagué (5 shared papers)Qiaoran Xi (3 shared papers)Nina Goerner (2 shared papers)Albert Escobedo (2 shared papers)Tiago Gomes (6 shared papers)Pau Martín-Malpartida (15 shared papers)Lidia Ruíz (10 shared papers)
- Journals
- Nature Communications (4 papers)The Journal of Clinical Pharmacology (3 papers)Computational and Structural Biotechnology Journal (2 papers)Genes & Development (2 papers)Structure (2 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Eric Aragón
27 papers receiving 826 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 544
- Cell Biology 117
- Structural Biology 9
- Oncology 110
- Pathology and Forensic Medicine 60
Countries citing papers authored by Eric Aragón
This map shows the geographic impact of Eric Aragón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Aragón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Aragón more than expected).
Fields of papers citing papers by Eric Aragón
This network shows the impact of papers produced by Eric Aragón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Aragón. The network helps show where Eric Aragón may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Aragón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 210 | |
| 2 | 2017 | 93 | |
| 3 | 2012 | 84 | |
| 4 | 2019 | 74 | |
| 5 | 2008 | 54 | |
| 6 | 2014 | 53 | |
| 7 | 2018 | 36 | |
| 8 | 1989 | 32 | |
| 9 | 2021 | 24 | |
| 10 | 2013 | 21 | |
| 11 | 2011 | 19 | |
| 12 | 2006 | 19 | |
| 13 | 2021 | 17 | |
| 14 | Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone. | 1988 | 14 |
| 15 | 2022 | 13 | |
| 16 | 2013 | 12 | |
| 17 | 2001 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2016 | 9 | |
| 20 | 2009 | 8 |
About Eric Aragón
Eric Aragón is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine, Cell Biology and Pathology and Forensic Medicine, having authored 27 papers that have together received 842 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (6 papers), Cancer-related gene regulation (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cardiac Arrhythmias and Treatments (4 papers), Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Molecular Biology (544 citations), Cell Biology (117 citations), Structural Biology (9 citations), Oncology (110 citations) and Pathology and Forensic Medicine (60 citations). Eric Aragón has collaborated with scholars based in Spain, United States and France. Frequent co-authors include María J. Macias, Joan Massagué, Qiaoran Xi, Nina Goerner, Albert Escobedo, Tiago Gomes, Pau Martín-Malpartida, Lidia Ruíz, Alexia-Ileana Zaromytidou and Zuzanna Kaczmarska. Their work appears in journals such as Nature Communications, The Journal of Clinical Pharmacology, Computational and Structural Biotechnology Journal, Genes & Development and Structure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.